The population of patients with conotruncal cardiac malformations at-risk for deletions of 22q11.21 to q11.23 is large. Therefore, a rapid DNA- based screening method to detect individuals at high risk for deletions will be required. Thus, we propose to develop and apply a multiplex PCR- based screening assay using highly polymorphic DNA markers. Individuals at risk for deletions will be further screened by fluorescence in situ hybridization (FISH) utilizing 22q11.2-specific cosmid clones which span and flank the cardiac critical region. Utilization of multi-colored fluors for simultaneous hybridization of multiple probes to interphase nuclei will help us to estimate the extent of deletions for selected individuals. We will test the hypothesis that differences in size, location, parent of origin, and etiology of the deletions within 22q11 account for the phenotypic variability observed between CCHD patients with deletions. Furthermore, we suggest that variability in the clinical manifestations between affected members of families may result from change in the size of an inherited deletion during meiosis. To test this hypothesis, we will correlate the size and location of the deletions with the clinical findings the genes discovered and their expression pattern. We will compare the size of deletions in multiple affected family members and test for imprinting effects by determining the parent of origin in patients with deletions. Finally, we propose that 22q11 may rearrange by centromeric exchange with other acrocentric chromosomes. We will examine the prevalence of such """"""""cryptic translocations"""""""" as a mechanism associated with generating 22q11.2 deletions. Finally, we propose that the conotruncal heart defects may be caused by abnormalities of a single gene in the cardiac critical region. To test this hypothesis, we will examine the evidence for the presence of a cardiac critical region in 22q11.21 to 22q11.23 by examining locus associations in CHD families or looking for mutations in specific """"""""candidate"""""""" genes in non-deleted patients.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL051533-03
Application #
5214099
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
D'Alessandro, Lisa C A; Latney, Brande C; Paluru, Prasuna C et al. (2013) The phenotypic spectrum of ZIC3 mutations includes isolated d-transposition of the great arteries and double outlet right ventricle. Am J Med Genet A 161A:792-802
Chen, J-R; Chatterjee, B; Meyer, R et al. (2004) Tbx2 represses expression of Connexin43 in osteoblastic-like cells. Calcif Tissue Int 74:561-73
Goldmuntz, Elizabeth; Bamford, Richard; Karkera, Jayaprakash D et al. (2002) CFC1 mutations in patients with transposition of the great arteries and double-outlet right ventricle. Am J Hum Genet 70:776-80
Goldmuntz, E; Geiger, E; Benson, D W (2001) NKX2.5 mutations in patients with tetralogy of fallot. Circulation 104:2565-8
Driscoll, D A (2001) Prenatal diagnosis of the 22q11.2 deletion syndrome. Genet Med 3:14-8
Lund, J; Chen, F; Hua, A et al. (2000) Comparative sequence analysis of 634 kb of the mouse chromosome 16 region of conserved synteny with the human velocardiofacial syndrome region on chromosome 22q11.2. Genomics 63:374-83
Li, Y X; Farrell, M J; Liu, R et al. (2000) Double-stranded RNA injection produces null phenotypes in zebrafish. Dev Biol 217:394-405
Galili, N; Nayak, S; Epstein, J A et al. (2000) Rnf4, a RING protein expressed in the developing nervous and reproductive systems, interacts with Gscl, a gene within the DiGeorge critical region. Dev Dyn 218:102-11
Lund, J; Roe, B; Chen, F et al. (1999) Sequence-ready physical map of the mouse chromosome 16 region with conserved synteny to the human velocardiofacial syndrome region on 22q11.2. Mamm Genome 10:438-43
Waldo, K L; Lo, C W; Kirby, M L (1999) Connexin 43 expression reflects neural crest patterns during cardiovascular development. Dev Biol 208:307-23

Showing the most recent 10 out of 49 publications